LIVE VIEW · PCRXPacira BioSciences, Inc.PharmaceuticalsPCRX research Sign up to open the full interactive terminal, save boards, and get alerts
PCRX · Live chart
Loading live chart
PCRX · Smart-money compositeas of Aug 14
-9NEUTRALsmart-money positioning
-100 short0+100 long
InsiderSHORT
Congressno congressional trade in t...
13F fundsLONG
Short volumeFINRA short-volume is not c...
2 of 4 families contributing
PCRX · Recent signals
Q2-2026: Beat consensus by 10.6%, EPS $0.73 vs $0.6603 estimateMEDIUMLONGAug 5
MILLENNIUM MANAGEMENT LLC cut 53% of PCRX (2026Q1)HIGHSHORTJul 24
Q3-2025: Beat consensus by 5.3% - EPS $0.7 vs $0.6649 estimateMEDIUMLONGJun 2
Q4-2025: Missed consensus by 38.2% - EPS $0.57 vs $0.9225 estimateMEDIUMSHORTJun 2
PCRX · Institutional holdersas of 2025Q3
RENAISSANCE TECHNOLOGIES LLC$55.1Mn/a
D. E. Shaw & Co., Inc.$52.8M+4202.5%
RENAISSANCE TECHNOLOGIES LLC$48.8M-11.9%
D. E. Shaw & Co., Inc.$44.8M-2.8%
RENAISSANCE TECHNOLOGIES LLC$41.3M-3.1%
TWO SIGMA INVESTMENTS, LP$11.9M+16.6%
TWO SIGMA INVESTMENTS, LP$11.7M+93.9%
D. E. Shaw & Co., Inc.$6.1Mn/a
Live alerts on PCRX
Live alerts on PCRXGet pinged the moment insiders, congress, or 13F funds move on PCRX.Sign up to unlock
Options positioning and dealer gamma
Options positioning and dealer gammaDealer gamma, call and put walls, and expiry pressure for PCRX.Sign up to unlock
Build your own board
Build your own boardEvery ticker, your own layout, saved boards, and alerts in one terminal.Sign up to unlock